Radioimaging of Melanoma and CEA Secreting Tumours by Monoclonal Antibodies Performed by Different Routes of Administration View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1988

AUTHORS

Pietro Riva

ABSTRACT

Alternative routes of administration of radiolabelled antitumor monoclonal antibodies were investigated in order to try to overcome some of the limitations of the immunoscintigraphic method observed by using the intravenous route of administration. Such limitations are: a) the high vascular background due to circulating radiolabelled antibodies and possibly to circulating immunocomplexes; b) the high accumulation of radioactivity in liver, spleen and bone marrow, due to nonspecific uptake of antibodies and immunocomplexes, and possibly of degradation products which develop in vivo after the injection; and c) the catabolic degradation of monoclonal antibodies with consequent release of free isotopes that are picked up by their respective critical organs — thyroid, salivary glands, stomach, liver, bone marrow, etc. All these phenomena give rise to a lowering of the signal coming from the target tumor which cannot be easily differentiated from the surrounding tissues. We are then forced in some instances to use dual tracer subtraction techniques, which are particularly useful when I-131 is employed as a label. More... »

PAGES

701-714

Book

TITLE

Radiolabeled Monoclonal Antibodies for Imaging and Therapy

ISBN

978-1-4684-5540-3
978-1-4684-5538-0

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4684-5538-0_44

DOI

http://dx.doi.org/10.1007/978-1-4684-5538-0_44

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053488989


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Reparto di Medicina Nucleare, Ospedale M. Bufalini, Cesena, Italy", 
          "id": "http://www.grid.ac/institutes/grid.414682.d", 
          "name": [
            "Reparto di Medicina Nucleare, Ospedale M. Bufalini, Cesena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Riva", 
        "givenName": "Pietro", 
        "id": "sg:person.01177547630.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177547630.17"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1988", 
    "datePublishedReg": "1988-01-01", 
    "description": "Alternative routes of administration of radiolabelled antitumor monoclonal antibodies were investigated in order to try to overcome some of the limitations of the immunoscintigraphic method observed by using the intravenous route of administration. Such limitations are: a) the high vascular background due to circulating radiolabelled antibodies and possibly to circulating immunocomplexes; b) the high accumulation of radioactivity in liver, spleen and bone marrow, due to nonspecific uptake of antibodies and immunocomplexes, and possibly of degradation products which develop in vivo after the injection; and c) the catabolic degradation of monoclonal antibodies with consequent release of free isotopes that are picked up by their respective critical organs \u2014 thyroid, salivary glands, stomach, liver, bone marrow, etc. All these phenomena give rise to a lowering of the signal coming from the target tumor which cannot be easily differentiated from the surrounding tissues. We are then forced in some instances to use dual tracer subtraction techniques, which are particularly useful when I-131 is employed as a label.", 
    "editor": [
      {
        "familyName": "Srivastava", 
        "givenName": "Suresh C.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4684-5538-0_44", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4684-5540-3", 
        "978-1-4684-5538-0"
      ], 
      "name": "Radiolabeled Monoclonal Antibodies for Imaging and Therapy", 
      "type": "Book"
    }, 
    "keywords": [
      "monoclonal antibodies", 
      "bone marrow", 
      "antitumor monoclonal antibodies", 
      "secreting tumor", 
      "vascular background", 
      "intravenous route", 
      "radiolabelled antibodies", 
      "immunoscintigraphic methods", 
      "target tumor", 
      "salivary glands", 
      "antibodies", 
      "nonspecific uptake", 
      "administration", 
      "tumors", 
      "marrow", 
      "liver", 
      "free isotope", 
      "consequent release", 
      "spleen", 
      "melanoma", 
      "stomach", 
      "catabolic degradation", 
      "I-131", 
      "gland", 
      "different routes", 
      "injection", 
      "vivo", 
      "tissue", 
      "higher accumulation", 
      "radioactivity", 
      "immunocomplexes", 
      "release", 
      "uptake", 
      "degradation products", 
      "subtraction technique", 
      "background", 
      "route", 
      "accumulation", 
      "lowering", 
      "alternative route", 
      "limitations", 
      "rise", 
      "labels", 
      "technique", 
      "method", 
      "instances", 
      "such limitations", 
      "products", 
      "signals", 
      "degradation", 
      "phenomenon", 
      "order", 
      "isotopes", 
      "radiolabelled antitumor monoclonal antibodies", 
      "high vascular background", 
      "dual tracer subtraction techniques", 
      "tracer subtraction techniques", 
      "CEA Secreting Tumours"
    ], 
    "name": "Radioimaging of Melanoma and CEA Secreting Tumours by Monoclonal Antibodies Performed by Different Routes of Administration", 
    "pagination": "701-714", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053488989"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4684-5538-0_44"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4684-5538-0_44", 
      "https://app.dimensions.ai/details/publication/pub.1053488989"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-01-01T19:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/chapter/chapter_45.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4684-5538-0_44"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5538-0_44'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5538-0_44'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5538-0_44'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-5538-0_44'


 

This table displays all metadata directly associated to this object as RDF triples.

118 TRIPLES      23 PREDICATES      84 URIs      77 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4684-5538-0_44 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nad2f3a3f3e754bedbb043420d52a4b66
4 schema:datePublished 1988
5 schema:datePublishedReg 1988-01-01
6 schema:description Alternative routes of administration of radiolabelled antitumor monoclonal antibodies were investigated in order to try to overcome some of the limitations of the immunoscintigraphic method observed by using the intravenous route of administration. Such limitations are: a) the high vascular background due to circulating radiolabelled antibodies and possibly to circulating immunocomplexes; b) the high accumulation of radioactivity in liver, spleen and bone marrow, due to nonspecific uptake of antibodies and immunocomplexes, and possibly of degradation products which develop in vivo after the injection; and c) the catabolic degradation of monoclonal antibodies with consequent release of free isotopes that are picked up by their respective critical organs — thyroid, salivary glands, stomach, liver, bone marrow, etc. All these phenomena give rise to a lowering of the signal coming from the target tumor which cannot be easily differentiated from the surrounding tissues. We are then forced in some instances to use dual tracer subtraction techniques, which are particularly useful when I-131 is employed as a label.
7 schema:editor N5f1372935d2646fc90cfd669e5c164c2
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf Nfad3c85afb954c6498cc88e10cd97a02
12 schema:keywords CEA Secreting Tumours
13 I-131
14 accumulation
15 administration
16 alternative route
17 antibodies
18 antitumor monoclonal antibodies
19 background
20 bone marrow
21 catabolic degradation
22 consequent release
23 degradation
24 degradation products
25 different routes
26 dual tracer subtraction techniques
27 free isotope
28 gland
29 high vascular background
30 higher accumulation
31 immunocomplexes
32 immunoscintigraphic methods
33 injection
34 instances
35 intravenous route
36 isotopes
37 labels
38 limitations
39 liver
40 lowering
41 marrow
42 melanoma
43 method
44 monoclonal antibodies
45 nonspecific uptake
46 order
47 phenomenon
48 products
49 radioactivity
50 radiolabelled antibodies
51 radiolabelled antitumor monoclonal antibodies
52 release
53 rise
54 route
55 salivary glands
56 secreting tumor
57 signals
58 spleen
59 stomach
60 subtraction technique
61 such limitations
62 target tumor
63 technique
64 tissue
65 tracer subtraction techniques
66 tumors
67 uptake
68 vascular background
69 vivo
70 schema:name Radioimaging of Melanoma and CEA Secreting Tumours by Monoclonal Antibodies Performed by Different Routes of Administration
71 schema:pagination 701-714
72 schema:productId Nade89721f449451aa345beb0ed1553a8
73 Ndc33b9aace92441c84aa88fcbf2b3abd
74 schema:publisher N913b39a843d74b11996ace014cf16b0b
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053488989
76 https://doi.org/10.1007/978-1-4684-5538-0_44
77 schema:sdDatePublished 2022-01-01T19:26
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N82345fa2c4fb4792be5a2a1107af7528
80 schema:url https://doi.org/10.1007/978-1-4684-5538-0_44
81 sgo:license sg:explorer/license/
82 sgo:sdDataset chapters
83 rdf:type schema:Chapter
84 N5f1372935d2646fc90cfd669e5c164c2 rdf:first Ncdaffb4ec14242a78cac936f7720fc7d
85 rdf:rest rdf:nil
86 N82345fa2c4fb4792be5a2a1107af7528 schema:name Springer Nature - SN SciGraph project
87 rdf:type schema:Organization
88 N913b39a843d74b11996ace014cf16b0b schema:name Springer Nature
89 rdf:type schema:Organisation
90 Nad2f3a3f3e754bedbb043420d52a4b66 rdf:first sg:person.01177547630.17
91 rdf:rest rdf:nil
92 Nade89721f449451aa345beb0ed1553a8 schema:name doi
93 schema:value 10.1007/978-1-4684-5538-0_44
94 rdf:type schema:PropertyValue
95 Ncdaffb4ec14242a78cac936f7720fc7d schema:familyName Srivastava
96 schema:givenName Suresh C.
97 rdf:type schema:Person
98 Ndc33b9aace92441c84aa88fcbf2b3abd schema:name dimensions_id
99 schema:value pub.1053488989
100 rdf:type schema:PropertyValue
101 Nfad3c85afb954c6498cc88e10cd97a02 schema:isbn 978-1-4684-5538-0
102 978-1-4684-5540-3
103 schema:name Radiolabeled Monoclonal Antibodies for Imaging and Therapy
104 rdf:type schema:Book
105 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical and Health Sciences
107 rdf:type schema:DefinedTerm
108 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
109 schema:name Clinical Sciences
110 rdf:type schema:DefinedTerm
111 sg:person.01177547630.17 schema:affiliation grid-institutes:grid.414682.d
112 schema:familyName Riva
113 schema:givenName Pietro
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177547630.17
115 rdf:type schema:Person
116 grid-institutes:grid.414682.d schema:alternateName Reparto di Medicina Nucleare, Ospedale M. Bufalini, Cesena, Italy
117 schema:name Reparto di Medicina Nucleare, Ospedale M. Bufalini, Cesena, Italy
118 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...